Taysha Gene Therapies, Inc. - Common Stock (TSHA)
1.5250
+0.0450 (3.04%)
Taysha Gene Therapies Inc is a biotechnology company focused on developing and delivering innovative gene therapies for the treatment of various neurological diseases, particularly genetic disorders that impact the central nervous system
By leveraging advanced technologies, Taysha aims to create transformative therapies that address the underlying causes of these diseases, providing hope for patients with limited treatment options. The company's research and development efforts emphasize collaboration with leading academic institutions and experts to advance its pipeline of gene therapy products toward clinical application.
| Previous Close | 1.480 |
|---|---|
| Open | 1.490 |
| Bid | 1.520 |
| Ask | 1.530 |
| Day's Range | 1.480 - 1.540 |
| 52 Week Range | 1.190 - 4.320 |
| Volume | 310,351 |
| Market Cap | 98.31M |
| PE Ratio (TTM) | 2.421 |
| EPS (TTM) | 0.6 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 2,122,081 |
